tm
Seeing Is Believing
tm
Seeing Is Believing
ARWR is currently covered by 12 analysts with an average potential upside of $16.04 (50.61%) backed by displayed 119 price targets and 131 ratings.
Analysts average stock forecasts to be materialized ratio is 65.53% with an average time for these price targets to be met of 249.12 days.
Highest price target for ARWR is 54, Lowest price target is 26, average price target is 40.
Most recent stock forecast was given by LUCA ISSI from RBC on 30-Nov-2023. First documented stock forecast 18-Dec-2013.
Currently, out of the existing stock ratings of ARWR - 30 which are a Buy (81.08%), 7 which are a Hold (18.92%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
50
$21.02 (72.53%)
1 days ago
2/4 (50%)
$21.64 (52.25%)
100
Hold
33
$4.02 (13.87%)
90
2 months 12 days ago
2/3 (66.67%)
$9.48 (17.86%)
108
Buy
90
$63.13 (234.95%)
90
3 months 22 days ago
0/8 (0%)
$50.32 (143.58%)
Buy
60
3 months 23 days ago
3/10 (30%)
$22.46 (53.04%)
169
Buy
47
$18.02 (62.18%)
80
3 months 23 days ago
6/7 (85.71%)
$11.17 (35.86%)
436
What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?
